凝血因子,血小板和血原体的互联世界:生物合成调节的新视角
Ivan Bergo1, Mark Slevin2, Ylenia Pastorello3
1Faculty of Medicine in English Campus Hamburg, George Emil Palade University of Medicine, Pharmacy, Science and Technology, 540139 Târgu Mureș, Romania.
Life (Basel, Switzerland)
|October 29, 2025
概括
血小板通过涉及纤维素降解产物 (FgDPs) 和介质素-6 (IL-6) 的新途径影响血小板对血小板计数 (TPO) 调节,从而挑战了对TPO恒温的以血小板计数为中心的观点.
科学领域:
- 血液学 血液学 血液学
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 血小板传统上以凝血和通过吸收对血栓形成素 (TPO) 的调节而闻名.
- 人们越来越认识到TPO稳态是涉及动态反机制的.
- 血小板亚群和与纤维解和细胞因子信号的相互作用增加了血液静止和血液形成的复杂性.
研究的目的:
- 研究将纤维素降解产物 (FgDPs) 与等离子素和TPO合成联系起来的新途径.
- 为了探索血小板前凝剂,血小板衍生的信使和纤维溶解过程之间的相互联系.
- 挑战TPO恒温的以血小板计数为中心的范式.
主要方法:
- 假设中间机制,如FgDP-IL-6-plasminogen和PAF-IL-6-TPO路径.
- 建议通过血小板前凝剂分泌血小板激活因子 (PAF),诱导IL-6合成.
- 表明IL-6刺激肝脏TPO生产作为一个反循环.
主要成果:
- FgDPs可能会增强IL-6的释放,这表明了TPO调节的替代途径.
- 拟议的途径将FgDPs和等离子体生物合成与血小板激活和TPO调节联系起来.
- 假设的机制包括血小板激活,细胞因子释放和血栓形成调节.
结论:
- 炎症和纤维溶解信号积极调节TPO恒温,而不仅仅是血小板计数.
- 提供了对血液形成和TPO调节的新见解.
- 建议针对血小板缺血和凝血障碍的潜在治疗点.
相关概念视频
01:22Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
01:16Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:05Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K
01:09Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K